Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy

Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy

Bibliographic Details
Main Author:	Joud Hajjar
Format:	Article
Language:	English
Published:	Innovative Healthcare Institute 2019-08-01
Series:	Journal of Immunotherapy and Precision Oncology
Online Access:	https://jipo.org/doi/pdf/10.4103/JIPO.JIPO_15_19

Similar Items

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
by: Irina Petrache, et al.
Published: (2009-05-01)

Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
by: Xin Cui, et al.
Published: (2020-09-01)

The Conundrum of Anticoagulation and Antiplatelet Therapy in Spontaneous Coronary Artery Dissection
by: Andres Cordova Sanchez MC, et al.
Published: (2022-05-01)

Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
by: Shalini K. Sureshbabu, et al.
Published: (2021-08-01)

The immune system, cancer, and pathogens: It takes three to tango!
by: Joud Hajjar
Published: (2021-05-01)

The breast cancer conundrum

The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
by: Pengfei Xu, et al.
Published: (2022-07-01)

Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
by: Qi Wei, et al.
Published: (2022-10-01)

Role of the immunosuppressive microenvironment in immunotherapy
by: Garth W. Tormoen, MD, PhD, et al.
Published: (2018-10-01)

A cough conundrum in a patient with a previous history of BCG immunotherapy for bladder cancer.
by: Mehta, A, et al.
Published: (2012)

Pure white cell aplasia an exceptional condition in the immunological conundrum of thymomas: Responses to immunosuppression and literature review
by: Roberto Céspedes López, et al.
Published: (2022-05-01)

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
by: Weiqiang Lu, et al.
Published: (2021-01-01)

Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
by: Augusto Bleve, et al.
Published: (2020-08-01)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
by: Mithunah Krishnamoorthy, et al.
Published: (2021-05-01)

Cancer Immunotherapy in the Immunosuppressed Patients and Its Relevance to Clinical Practice
by: Vaia Florou, et al.
Published: (2019-10-01)

2025 Targeting immunosuppressive myeloid cells to enhance cancer immunotherapy
by: Xin Lu
Published: (2018-06-01)

Understanding sepsis-induced immunosuppression and organ dysfunctions: from immunosuppression to immunotherapy
by: Dablu Lal Gupta, et al.
Published: (2022-08-01)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
by: Xuehua Zhang, et al.
Published: (2022-11-01)

Computational dissection and prediction of cancer immunotherapy response
by: Shi, Alvin
Published: (2022)

Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
by: Clara Martín-Carrasco, et al.
Published: (2022-06-01)

Efficacy and safety of endoscopic submucosal dissection for superficial cancer of the cervical esophagus
by: Toshiro Iizuka, et al.
Published: (2017-08-01)

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
by: Songtao Du, et al.
Published: (2023-02-01)

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
by: Yanyan Xu, et al.
Published: (2022-12-01)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
by: Hu Chen, et al.
Published: (2022-06-01)

Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
by: Amber J. Giles, et al.
Published: (2018-06-01)

Clinical conundrum.
by: Soin, B, et al.
Published: (2003)

The NSF Conundrum
by: Hrishikesh Kale, et al.

The pricing conundrum
by: Toh, Yixue
Published: (2022)

Compensation conundrum
by: Shoibal Mukherjee
Published: (2012-01-01)

The subspecialization conundrum
by: Bhavin Jankharia
Published: (2010-01-01)

The Alzheimer conundrum
by: Jolanda Lindenberg
Published: (2014-12-01)

The subspecialization conundrum
by: Jankharia Bhavin
Published: (2010-01-01)

The subspecialty conundrum
by: Krishnamurthy Rajesh
Published: (2010-01-01)

The subspecialty conundrum
by: Rajesh Krishnamurthy
Published: (2010-07-01)

SLE Conundrums
by: Wardle E
Published: (2010-01-01)

The ethical conundrum
by: Sharmila Devi Vadivelu
Published: (2022-01-01)

Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection
by: Zhongru Fan, et al.
Published: (2024-01-01)

Dunn's conundrum /
by: 459202 Lee, Stan
Published: (1985)

The novel use of zwitterionic bacterial components and polysaccharides in immunotherapy of cancer and immunosuppressed cancer patients.
by: Abdulamir, Ahmed Sahib, et al.
Published: (2012)

Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
by: Zhe Fu, et al.
Published: (2021-04-01)